Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
28
AURA Quote, Financials, Valuation and Earnings
Last price:
$5.87
Seasonality move
:
-3.99%
Day range:
$5.72 - $5.92
52-week range:
$4.35 - $8.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.38x
Volume:
99.1K
Avg. volume:
188.5K
1-year change:
-30.2%
Market cap:
$372.8M
Revenue:
--
EPS (TTM):
-$1.93
Earnings Data
Next earnings date for AURA
Mar 30
2026
Most recent earnings per share
-$0.40
Missed by $0.40
(Nov 13/2025)
Consensus Estimate
--
(Nov 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
AURA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/30/2026 | Q4 | -- | -- | -- | -- | -- |
| 11/13/2025 | Q3 | -- | -- | -$0.40 | -- | -- |
| 08/13/2025 | Q2 | -- | -- | -$0.47 | -- | -- |
| 05/08/2025 | Q1 | -- | -- | -$0.55 | -- | -- |
| 03/24/2025 | Q4 | -- | -- | -$0.52 | -- | -- |
| 11/12/2024 | Q3 | -- | -- | -$0.42 | -- | -- |
| 08/08/2024 | Q2 | -- | -- | -$0.41 | -- | -- |
| 05/09/2024 | Q1 | -- | -- | -$0.40 | -- | -- |
| 03/27/2024 | Q4 | -- | -- | -$0.50 | -- | -- |
| 11/09/2023 | Q3 | -- | -- | -$0.48 | -- | -- |
| 08/09/2023 | Q2 | -- | -- | -$0.48 | -- | -- |
| 05/11/2023 | Q1 | -- | -- | -$0.46 | -- | -- |
| 03/15/2023 | Q4 | -- | -- | -$0.52 | -- | -- |
| 11/10/2022 | Q3 | -- | -- | -$0.54 | -- | -- |
| 08/11/2022 | Q2 | -- | -- | -$0.46 | -- | -- |
| 05/12/2022 | Q1 | -- | -- | -$0.44 | -- | -- |
| 03/23/2022 | Q4 | -- | -- | -$0.44 | -- | -- |
| 11/24/2021 | Q3 | -- | -- | -$0.43 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.43 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.28 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.24 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.19 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.28 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.32 | -- | -- |
Aura Biosciences, Inc. Earnings Questions
-
How Much did Aura Biosciences, Inc. Generate in Revenue Last Quarter?
Aura Biosciences, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Aura Biosciences, Inc. Beat Earnings Last Quarter?
Aura Biosciences, Inc. announced earnings per share of -$0.40 which represents a miss of analyst forecast a -- per share.
-
Is Aura Biosciences, Inc. Profitable?
Aura Biosciences, Inc. reported -$300K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Aura Biosciences, Inc. EPS Next Year?
Aura Biosciences, Inc.'s earnings are forecast to decrease from -$1.75 per share to -$1.18 per share next year representing a decrease of -39.8%.
-
When is Aura Biosciences, Inc.'s Earnings Date?
Aura Biosciences, Inc.'s next earnings date is March 30, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
